The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of systemic inflammation in early-stage breast cancer in the CANTO cohort (SIM-CANTO).
 
Julia Dixon-Douglas
Honoraria - Gilead Lide
 
Julie Havas
No Relationships to Disclose
 
Federica Giugliano
No Relationships to Disclose
 
Thi Hoai Hoang
No Relationships to Disclose
 
Alessandro Viansone
Honoraria - Seagen
Consulting or Advisory Role - Seagen
Speakers' Bureau - AstraZeneca/Daiichi Sankyo
Research Funding - Pfizer
Expert Testimony - Seagen
Travel, Accommodations, Expenses - Eisai Europe
 
Jean Zeghondy
Travel, Accommodations, Expenses - Novartis
 
Anne-Laure Martin
No Relationships to Disclose
 
Dominique Delmas
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; Olema Oncology (Inst); PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
William Jacot
Honoraria - AstraZeneca; BMSi; Daiichi Sankyo Europe GmbH; Eisai; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; BMSi; Daiichi Sankyo Europe GmbH; Eisai; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca/Daiichi Sankyo (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
 
Coureche Kaderbhai
No Relationships to Disclose
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sandoz-Novartis; Stemline Therapeutics; Veracyte
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Paul Cottu
Honoraria - AstraZeneca; Daiich Sankyo; Gilead Sciences; Gilead Sciences; Gilead Sciences; Lilly; Menarini; Novartis (Inst); Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); MSD (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Lilly; pfizer; Roche
 
Mario Campone
Honoraria - Pfizer (Inst)
Consulting or Advisory Role - Pfizer (Inst)
Speakers' Bureau - Lilly (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
 
Carole Tarpin
No Relationships to Disclose
 
Fabrice Andre
Consulting or Advisory Role - AstraZeneca (Inst); Boston Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Lilly; Lilly (Inst); N-Power Medicine (Inst); Novartis (Inst); Owkin (Inst); Pfizer (Inst); ROCHE (Inst); SERVIER (Inst)
Research Funding - AstraZeneca (Inst); Daiichi (Inst); Guardant Health (Inst); Lilly (Inst); Novartis (Inst); Owkin (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
Antonio Di Meglio
Expert Testimony - Kephren; techspert.io
 
Ines Luis
Honoraria - AstraZeneca (Inst); Chugai Pharma (Inst); Institut de recherches internationales Servier (Inst); Novartis (Inst); Sandoz; Servier Monde (Inst)
Research Funding - Resilience Care (Inst)
Travel, Accommodations, Expenses - Novartis; Novartis
 
Chayma Bousrih
No Relationships to Disclose
 
Joana Ribeiro
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Novartis; Roche